The Escalating Problem & Cost of Antimicrobial Resistance
FEB 16, 2018 | CONTAGION® EDITORIAL STAFF
Glenn Tillotson, PhD, FIDSA, consultant microbiologist in Durham, NC, provides insight into the growing problem and cost of antimicrobial resistance.
Interview Transcript (modified slightly for readability):
“I think antibiotic resistance, often called antimicrobial resistance, or AMR, is now recognized by the United Nations, the World Health Organization (WHO), President Obama, the Centers for Disease Control and Prevention—all of the major entities in the world recognize that AMR is a major problem. It is responsible for 23 million deaths, 2 million extra infections, and so, this is causing a major concern health wise.
The issue with AMR is that it’s like a train and it’s out of the station and is picking up speed. Unless we do something to curtail that, then we have a growing problem. There is a group in the United Kingdom led by Lord O’Neill and Lord O’Neill published a report 2 years ago that estimates that by the year 2030, we’ll be spending about $50 billion extra in health care dollars to cope with AMR. And so, it is an escalating problem. AMR is actually mentioned in the WHO’s top 5 health care crises; I think it’s in at number 3. But certainly, it’s in WHO’s top bad problems.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512